Article | September 20, 2021

How Modularity Is A Clear Winner When It Comes To Flexibility And Scalability In Drug Delivery Device Assembly

Stevanato Group -DSC06895

Combination products are on the increase for a range of therapies – from low-volume orphan drugs to high-volume pharmaceuticals and the latest biologics and biosimilars.

In particular, the demand for injectables has been growing over the last few years – largely due to an increase in chronic diseases that often require regular self-administration to ensure proper treatment. The most widespread is diabetes, which has long been a problem in the developed world and is now becoming more common in developing, large-population nations like India and China. Other instances where self-administration of injectables comes into play include the growing niche of targeted small-batch and even personalized medicines, including oncological formulations and certain biologics*.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: